Influence of amifostine on reconstitution of lymphocyte subpopulations after conventional- and high-dose chemotherapy in patients with germ cell tumor

Annals of Hematology

Volumn 81, Issue 12, 2002, Pages 717-722

  Rick, Oliver ^a   Beyer, J ^b   Schwella, N ^b   Siegert, W ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Amifostine; Germ cell tumor; High dose chemotherapy; Immune reconstitution

Indexed keywords

AMIFOSTINE; ANTIBIOTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IFOSFAMIDE; PACLITAXEL; THIOTEPA;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; BRAIN DISEASE; CELL COMPARTMENTALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; FEVER; GERM CELL TUMOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE SYSTEM; INFECTION; LEUKOPENIA; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MULTIPLE ORGAN FAILURE; NEUROTOXICITY; OSTEOMYELITIS; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE; STEM CELL MOBILIZATION;

ADULT; AMIFOSTINE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; GRAFT SURVIVAL; HEMATOPOIESIS; HUMANS; IMMUNE SYSTEM; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 0036959029     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0538-4     Document Type: Article

References (18)

1. Rick O, Siegert W, Beyer J (2001) Chemotherapy in patients with metastatic or relapsed germ-cell tumours. Cancer Treat Rev 27:283-288
2. Glover DJ, Glick JH, Weiler C, Hurowitz S, Kligerman MM (1986) WR-2721 protects against the hematological toxicity of cyclophosphamide: a controlled phase II trial. J Clin Oncol 4:584-588
3. Bettich DC, Anderson H, Ranson M, Meely K, Oster W, Thatcher N (1995) Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small cell lung cancer: a randomized phase II study. Br J Cancer 72:1551-1555
4. Schiller JH, Storer B, Berlin J, Wittenkeller J, Larson M, Pharo L, Larson M, Berry W (1996) Amifostine, cisplatin and vinblastine in metastatic non-small cell lung cancer: a report of high response rates and prolonged survival. J Clin Oncol 14:1913-1921
5. Taylor CW, Wang L, List AF, Fernandes D, Paine-Murrieta GD, Johnson CS, Capizzi RL (1997) Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumor cells is maintained. Eur J Cancer 33:1693-1698
6. DiPaola RS, Rodriguez R, Goodin S (1998) Amifostine and dose-intense paclitaxel in patients with advanced malignancies. Cancer Ther 1:11-17
7. Budd GT, Ganapathi R, Adelstein DJ, Pelley R, Olencki T, Petrus J, McLain D, Zhang J, Capizzi R, Bukowski RM (1997) Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumors. Cancer 80:1134-1140
8. Kemp G, Rose P, Lurain J, Berman M, Manetta A, Roullet B, Homesley H, Belpomme D, Glick J (1996) Amifostine pretreatment for protection against cyclophosphamide and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer. J Clin Oncol 14:2101-2112
9. Rick O, Beyer J, Schwella N, Schubart H, Schleicher J, Siegert W (2001) Assessment of amifostine as protection from chemotherapy-induced toxicities after conventional-dose and high-dose chemotherapy in patients with germ cell tumor. Ann Oncol 12:1151-1155
10. Talmadge JE, Reed E, Ino K, Kessinger A, Kuszynski C, Heimann D, Varney M, Jackson J, Vose JM, Bierman PJ (1997) Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 19:161-172
11. Scheid C, Pettengell R, Ghielmini M, Radford JA, Morgenstern GR, Stern PL, Crowther D (1995) Time-course of the recovery of cellular immune function after high-dose chemotherapy and peripheral blood progenitor cell transplantation for high-grade non-Hodgkin's lymphoma. Bone Marrow Transplant 15:901-906
12. Avigan D, Wu Z, Joyce R, Elias A, Richardson P, McDermott D, Levine J, Kennedy L, Giallombardo N, Hurley D, Gong J, Kufe D (2000) Immune reconstitution following highdose chemotherapy with stem cell rescue in patients with advanced breast cancer. Bone Marrow Transplant 26:169-176
13. Scambia G, Panici PB, Pierelli L, Baiocchi G, Rumi C, Menichella G, Foddai ML, Serafini R, Arno E, Bonanno G (1993) Immunological reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation for advanced ovarian cancer. Eur J Cancer 29A:1518-1522
14. Rick O, Bokemeyer C, Beyer J, Hartmann JT, Schwella N, Kingreen D, Neureither S, Metzner B, Casper J, Wandt H, Hartmann F, Schmoll HJ, Derigs G, Gerl A, Berdel WE, Kanz L, Siegert W (2001) Salvage treatment with paclitaxel, ifosfamide and cisplatin plus high-dose carboplatin, etoposide and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer. J Clin Oncol 19:81-88
15. Schwella N, Beyer J, Schwaner I, Heuft HG, Rick O, Huhn D, Serke S, Siegert W (1996) Impact of preleukapheresis cell counts on collection of results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer. J Clin Oncol 14:1114-1121
16. Serke S, Van Leesen A, Huhn D (1998) Quantitative fluorescence flow cytometry: a comparison of the three techniques for direct and indirect immunofluorescence. Cytometry 33:179-187
17. Roberts MM, To LB, Gillis D, Mundy J, Rawling C, Ng K, Juttner CA (1993) Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 12:469-475
18. Ashihara E, Shimazaki C, Yamagata N, Hirata T, Okawa K, Oku N, Goto H, Inaba T, Fujita N, Nakagawa M (1994) Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis. Bone Marrow Transplant 13:377-381